Home > Boards > US Listed > Biotechs > Avita Medical Ltd. (RCEL)

Two points.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
melody432 Member Profile
 
Followed By 2
Posts 535
Boards Moderated 0
Alias Born 07/12/16
160x600 placeholder
AVITA Medical Limited Proposed Redomiciliation to the United States of America – Satisfaction of FIRB Condition Business Wire - 6/4/2020 9:00:00 PM
AVITA Medical Files RECELL® System Investigational Device Exemption (IDE) Application with the U.S. Food & Drug Administrati... Business Wire - 6/1/2020 9:28:00 PM
AVITA Medical to Participate at the Jefferies Virtual Healthcare Conference Business Wire - 5/21/2020 4:01:00 PM
AVITA Medical to Participate at Oppenheimer's MedTech Summit Business Wire - 5/13/2020 4:01:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/12/2020 11:00:49 AM
AVITA Medical Limited Proposed Redomiciliation to the United States of America – Registration of Scheme Booklet with ASIC &... Business Wire - 5/11/2020 4:31:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/11/2020 12:22:49 PM
AVITA Medical Limited Proposed redomiciliation to the United States of America – Federal Court of Australia orders convenin... Business Wire - 5/11/2020 11:47:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/29/2020 2:14:54 PM
AVITA Medical Reports Third Quarter Fiscal 2020 Financial Results and Company Update Business Wire - 4/29/2020 1:10:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/20/2020 5:25:55 PM
AVITA Medical Announces Intention to Redomicile to the United States of America Business Wire - 4/20/2020 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/15/2020 6:01:04 AM
AVITA Medical Provides Preliminary Top Line Results for the Third Quarter and COVID-19 Update Business Wire - 4/6/2020 8:00:00 AM
RECELL® System Data Accepted to 52nd Annual American Burn Association Meeting Available Online Business Wire - 4/1/2020 8:35:00 PM
First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL® System for Pediatric Scald Injuries Business Wire - 3/4/2020 4:01:00 PM
AVITA Medical to Attend the 2020 BTIG Healthcare Conference Business Wire - 3/3/2020 4:05:00 PM
First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction Business Wire - 3/2/2020 10:21:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/19/2020 4:28:21 PM
AVITA Medical Half-Year Financial Report for Fiscal 2020 Business Wire - 2/19/2020 1:04:00 AM
AVITA Medical to Present at the Cowen 40th Annual Health Care Conference Business Wire - 2/11/2020 4:05:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/3/2020 12:28:14 PM
AVITA Medical Reports Second Quarter Fiscal 2020 Financial Results and Company Update Business Wire - 1/30/2020 7:38:00 PM
AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Clinical Feasibility Study to Evaluate RECELL Sy... Business Wire - 12/29/2019 6:49:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/6/2019 6:02:01 AM
melody432   Friday, 03/27/20 07:04:45 PM
Re: bar1080 post# 5427
Post # of 5758 
Two points.

If the Vanguard purchases were due strictly to index funds they would have been buying last summer and fall when Avita was added to the S&P ASX300 and again when they were added to the S&P ASX200. Was not the case.

Secondly, the BNY Mellon shares are a regular addition (or at times subtraction) from the AVH depository shares they hold to back the RCEL shares for the US market. BNY merely holds the ordinary shares for which individual owners like you and me pay an annual fee ($.02/sh in 2019). This addition would indicate increased demand in the US market.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist